查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1959662

睡眠障礙市場機會、成長要素、產業趨勢分析及2026年至2035年預測

Sleep Disorder Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球睡眠障礙市場價值 305 億美元，預計到 2035 年將達到 786 億美元，年複合成長率為 9.8%。

睡眠障礙市場-IMG1

睡眠相關疾病發生率的上升、意識提升以及已開發市場和新興市場醫療保健系統診斷率的提高，共同推動了這一強勁的成長勢頭。診斷技術和篩檢方案的持續創新進一步加速了產業的擴張。醫療保健機構日益認知到睡眠健康是整體健康的重要組成部分，從而改善了篩檢技術和早期療育策略。同時，數位健康平台、互聯醫療設備和數據驅動療法的進步正在改變睡眠障礙的識別和管理方式。患者對便利、易用且科技驅動的醫療模式日益成長的需求，也為市場發展提供了助力。

市場範圍
開始年份 2025
預測期 2026-2035
起始值 305億美元
預測金額 786億美元
複合年成長率 9.8%

睡眠障礙是指影響睡眠品質、時間長度和時間的臨床疾病，會對日常生活和長期健康產生負面影響。這些疾病源自於生理、心理或行為因素，需要準確的診斷和系統的管理。由於居家診斷解決方案和遠距醫療模式的興起，睡眠障礙市場正在經歷顯著成長。攜帶式檢測系統和連網治療設備能夠實現即時數據採集和監測，從而減少對醫療機構診療的依賴。遠端醫療服務有助於最佳化診斷和治療，使更多人群能夠獲得醫療服務。隨著穿戴式監測設備和智慧睡眠追蹤系統的普及，消費者對睡眠健康管理的參與度也不斷提高。透過數位平台產生的數據正逐步整合到臨床工作流程中，從而促進個人化治療並提高患者依從性。

預計到2025年，睡眠呼吸中止症細分市場將佔據48.2%的市場。這一主導地位歸功於其高發病率、臨床認知度的提高以及家用診斷系統和持續治療技術的廣泛應用。代謝和生活方式相關風​​險因素的日益普遍，擴大了呼吸道相關睡眠障礙的高風險族群，直接推動了對診斷和治療方案的需求。人們對未經治療的呼吸相關睡眠障礙的健康影響的認知不斷提高，促進了積極篩檢和早期療育，進一步鞏固了該細分市場在整個睡眠障礙市場中的主導地位。

預計2026年至2035年，診斷領域將以9.1%的複合年成長率成長。市場成長的主要驅動力是人們日益重視睡眠障礙的早期檢測以及睡眠監測系統的持續技術進步。先進的監控工具，結合人工智慧驅動的數據分析和雲端整合平台，正在提高診斷準確性和營運效率。朝向更便捷、更人性化的檢測解決方案的轉變，持續推動著醫療保健領域的應用。

預計到2025年，北美睡眠障礙市場將佔據38.1%的佔有率。該地區受益於先進的診斷服務、專業的治療中心以及完善的醫療保健基礎設施，這些都為治療的廣泛應用提供了支持。醫護人員和病患對睡眠障礙與慢性疾病之間關聯的認知不斷提高，這促進了篩檢計畫和預防性照護的整合。技術先進的診斷工具和連網治療設備的普及進一步加速了市場滲透，並鞏固了該地區的市場主導地位。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源完整性通訊協定
  • 研究的可追蹤性和可靠性評分
    • 調查和路線的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估計值與計算
    • 兩種方法計算基準年均已完成。
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 調查透明度附錄
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 睡眠障礙盛行率增加
      • 睡眠診斷和治療技術的技術進步
      • 人們對睡眠健康的認知不斷提高
      • 治療睡眠障礙的攜帶式、高效能、高性能設備的需求日益成長。
    • 產業潛在風險與挑戰
      • 診斷和治療設備高成本
      • 發展中地區睡眠檢測設施進入受限
    • 市場機遇
      • 家庭睡眠檢測和治療的成長
      • 將人工智慧和數位健康融入睡眠管理
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 救贖方案
  • 未來市場趨勢
  • 消費者洞察
  • Start-Ups場景
  • 價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 公司矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章 市場估計與預測：依疾病類型分類，2022-2035年

  • 睡眠呼吸中止症
    • 阻塞型睡眠呼吸中止症症
    • 中樞性睡眠呼吸中止症
    • 複雜性睡眠呼吸中止症
  • 失眠
  • 不寧腿（RLS）
  • 嗜睡症
  • 其他疾病類型

第6章 市場估算與預測：依產品分類，2022-2035年

  • 治療設備
    • 治療設備
      • 正壓通氣（PAP）裝置
        • 持續性呼吸道正壓通氣（CPAP）裝置
        • 雙級正壓通氣（BiPAP）裝置
        • 自動正壓呼吸裝置（APAP）
      • 口內矯正器
        • 下顎前突裝置
        • 舌固定裝置
        • 快速上顎擴張
        • 護齒
      • 自適應伺服通氣（ASV）
      • 呼吸道清潔系統
      • 氧氣供應裝置
      • 其他醫療器材
    • 認知行為療法
  • 診斷設備
    • 睡眠多項生理檢查（PSG）設備
      • 攜帶式多導睡眠圖儀
      • 臨床多導睡眠圖設備
    • 居家睡眠監測（HST）設備
      • 類型 2
      • 3型
      • 4型
    • 活動記錄器系統
    • 睡眠篩檢設備
    • 脈動式血氧監測儀系統
    • 呼吸多導儀
    • 穿戴式裝置
      • 智慧型手錶和手環
      • 其他穿戴式裝置
    • 非穿戴式裝置

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 居家醫療機構和個人
  • 睡眠檢測機構和醫院

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Apple
  • BMC Medical
  • Cadwell
  • Drive Devilbiss
  • Fisher &Paykel Healthcare
  • Natus
  • Nihon Kohden
  • Oura Health
  • PHILIPS
  • ResMed
  • Sleep Shepherd
  • Sleepace
  • WEINMANN Medical
  • WITHINGS
  • ZOLL Medical
簡介目錄
Product Code: 5172

The Global Sleep Disorder Market was valued at USD 30.5 billion in 2025 and is estimated to grow at a CAGR of 9.8% to reach USD 78.6 billion by 2035.

Sleep Disorder Market - IMG1

The strong growth trajectory is driven by the rising incidence of sleep-related conditions, growing public awareness, and higher diagnosis rates across both developed and emerging healthcare systems. Continuous innovation in diagnostic technologies and therapeutic solutions is further accelerating industry expansion. Healthcare providers are increasingly recognizing sleep health as a critical component of overall well-being, leading to improved screening practices and early intervention strategies. In parallel, advancements in digital health platforms, connected medical devices, and data-driven treatment approaches are reshaping how sleep disorders are identified and managed. The market is also benefiting from growing patient demand for convenient, accessible, and technology-enabled care models.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$30.5 Billion
Forecast Value$78.6 Billion
CAGR9.8%

Sleep disorders are clinical conditions that interfere with sleep quality, duration, and timing, negatively affecting daily functioning and long-term health outcomes. These conditions arise from physiological, psychological, or behavioral factors and require accurate diagnosis and structured management. The sleep disorder market is experiencing notable expansion due to the transition toward home-based diagnostic solutions and remote care models. Portable testing systems and connected therapeutic devices enable real-time data collection and monitoring, reducing reliance on facility-based procedures. Telehealth services support consultation and treatment optimization, improving accessibility across broader populations. Consumer adoption of wearable monitoring devices and smart sleep tracking systems is increasing engagement in sleep health management. Data generated through digital platforms is progressively incorporated into clinical workflows, enhancing treatment personalization and improving patient adherence.

The sleep apnea segment held 48.2% share in 2025. Its dominance is attributed to high prevalence rates, expanding clinical awareness, and widespread utilization of home-based diagnostic systems and continuous therapeutic technologies. Increasing metabolic and lifestyle-related risk factors have expanded the population susceptible to airway-related sleep conditions, directly elevating demand for diagnostic and management solutions. Growing recognition of the health consequences associated with untreated breathing-related sleep disorders has encouraged proactive screening and early intervention, reinforcing this segment's leadership position within the broader sleep disorder market.

The diagnostics segment is projected to grow at a CAGR of 9.1% through 2026-2035. Market growth is being supported by rising emphasis on early identification of sleep abnormalities and continuous technological enhancements in sleep testing systems. Advanced monitoring tools, combined with artificial intelligence-enabled data analysis and cloud-integrated platforms, are improving diagnostic accuracy and operational efficiency. The shift toward accessible and patient-friendly testing solutions continues to stimulate adoption across healthcare settings.

North America Sleep Disorder Market held a 38.1% share in 2025. The region benefits from a well-developed healthcare infrastructure that supports advanced diagnostic services, specialized treatment centers, and widespread therapy adoption. Strong awareness among healthcare professionals and patients regarding the association between sleep disorders and chronic health conditions has strengthened screening initiatives and preventive healthcare integration. Availability of technologically advanced diagnostic tools and connected treatment devices further accelerates market penetration, reinforcing regional dominance.

Key companies operating in the Global Sleep Disorder Market include ResMed, PHILIPS, Apple, Fisher & Paykel Healthcare, Natus, Nihon Kohden, BMC Medical, Drive Devilbiss, Oura Health, Cadwell, Sleepace, WITHINGS, WEINMANN Medical, Sleep Shepherd, and ZOLL Medical. Companies in the sleep disorder market are reinforcing their competitive positioning through innovation, strategic collaborations, and portfolio diversification. Leading players are investing in research and development to introduce advanced diagnostic devices, connected therapeutic systems, and AI-enabled analytics platforms. Partnerships with healthcare providers and digital health firms are enhancing integrated care delivery and expanding market reach. Many organizations are focusing on expanding home-based testing solutions and remote monitoring capabilities to align with evolving patient preferences. Geographic expansion into high-growth regions and strengthening distribution networks are also key priorities.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Disorder type trends
    • 2.2.3 Product trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of sleep disorders
      • 3.2.1.2 Technological advancements in sleep diagnostics and therapeutics
      • 3.2.1.3 Growing awareness of sleep health
      • 3.2.1.4 Rising demand for portable, efficient, and superior devices for sleep disorders
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of diagnostic and therapeutic devices
      • 3.2.2.2 Limited access to sleep laboratories in developing regions
    • 3.2.3 Market opportunities
      • 3.2.3.1 Growth in home-based sleep testing and therapy
      • 3.2.3.2 Integration of AI and digital health in sleep management
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 Consumer insights
  • 3.9 Start-up scenarios
  • 3.10 Value chain analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Disorder Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Sleep apnea
    • 5.2.1 Obstructive sleep apnea
    • 5.2.2 Central sleep apnea
    • 5.2.3 Complex sleep apnea
  • 5.3 Insomnia
  • 5.4 Restless legs syndrome (RLS)
  • 5.5 Narcolepsy
  • 5.6 Other disorder types

Chapter 6 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Therapeutics
    • 6.2.1 Therapeutic devices
      • 6.2.1.1 Positive airway pressure (PAP) devices
        • 6.2.1.1.1 Continuous positive airway pressure (CPAP) devices
        • 6.2.1.1.2 Bilevel positive airway pressure (BiPAP) devices
        • 6.2.1.1.3 Automatic positive airway pressure (APAP) devices
      • 6.2.1.2 Oral appliances
        • 6.2.1.2.1 Mandibular advancement devices
        • 6.2.1.2.2 Tongue-retaining devices
        • 6.2.1.2.3 Rapid maxillary expansion
        • 6.2.1.2.4 Mouth guards
      • 6.2.1.3 Adaptive servo-ventilation (ASV)
      • 6.2.1.4 Airway clearance system
      • 6.2.1.5 Oxygen devices
      • 6.2.1.6 Other therapeutic devices
    • 6.2.2 Cognitive behavioral therapy
  • 6.3 Diagnostics
    • 6.3.1 Polysomnography (PSG) device
      • 6.3.1.1 Ambulatory PSG devices
      • 6.3.1.2 Clinical PSG devices
    • 6.3.2 Home sleep testing (HST) devices
      • 6.3.2.1 Type 2
      • 6.3.2.2 Type 3
      • 6.3.2.3 Type 4
    • 6.3.3 Actigraphy systems
    • 6.3.4 Sleep screening devices
    • 6.3.5 Pulse oximeter
    • 6.3.6 Respiratory polygraph
    • 6.3.7 Wearables
      • 6.3.7.1 Smart watches & bands
      • 6.3.7.2 Other wearables
    • 6.3.8 Non-wearbles

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Home care settings & individuals
  • 7.3 Sleep laboratories & hospitals

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Apple
  • 9.2 BMC Medical
  • 9.3 Cadwell
  • 9.4 Drive Devilbiss
  • 9.5 Fisher & Paykel Healthcare
  • 9.6 Natus
  • 9.7 Nihon Kohden
  • 9.8 Oura Health
  • 9.9 PHILIPS
  • 9.10 ResMed
  • 9.11 Sleep Shepherd
  • 9.12 Sleepace
  • 9.13 WEINMANN Medical
  • 9.14 WITHINGS
  • 9.15 ZOLL Medical